α-cyanopropenoic acid methylbutyl ester

• 分子结构分类: 有机化合物 - 有机酸及其衍生物 - 羧酸及其衍生物
• 英文名称: α-cyanopropenoic acid methylbutyl ester
• 英文别名: cyanopropenoic acid 1-methylbutyl ester；cyanopropenoic acid 2-pentyl ester；1-methylbutyl 2-cyanoacrylate；2-pentyl cyanoacrylate；Pentan-2-yl 2-cyanoprop-2-enoate；pentan-2-yl 2-cyanoprop-2-enoate
• 化学式: C₉H₁₃NO₂
• 分子量: 167.208
• InChiKey: SBPXGLQYUALAQV-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  2.3
• 重原子数：
  12
• 可旋转键数：
  5
• 环数：
  0.0
• sp3杂化的碳原子比例：
  0.56
• 拓扑面积：
  50.1
• 氢给体数：
  0
• 氢受体数：
  3

反应信息

• 作为产物：
  描述：

  聚合甲醛 、 2-戊醇 、 氰乙酸乙酯 在 硝基甲烷 、 ytterbium(III) triflate 作用下， 以 乙腈 为溶剂， 反应 12.5h， 生成 α-cyanopropenoic acid methylbutyl ester
  参考文献：
  名称：

  [EN] PROCESS FOR PREPARING ELECTRON DEFICIENT OLEFINS
  [FR] PROCÉDÉ DE PRÉPARATION D'OLÉFINES DÉFICIENTES EN ÉLECTRONS

  摘要：

  这项发明涉及一种制备电子亏损烯烃（如2-氰基丙烯酸酯）的过程，包括酸催化的两步反应，其中包括酯交换反应，然后是Knoevenagel缩合反应。

  公开号：

  WO2018114464A1

文献信息

• Composition, reaction product, kit and applicator, especially for use in medicine
  申请人：AESCULAP AG

  公开号：EP2708245A2

  公开（公告）日：2014-03-19

  The invention relates to a composition, especially for use in medicine, comprising a component a) containing cyanoacrylate monomers and an aqueous component b), wherein the composition further comprises an acid and a salt which reacts with the acid to release a gas. The invention further relates to a reaction product obtainable from the composition in the form of a porous and specifically shape-stable foamed structure in particular. The invention further relates to a kit comprising spatially separate from each other an acid component a) and a salt component b) and also to an applicator having a first chamber containing an acid component a) and a second chamber containing a salt component b).

  本发明涉及一种组合物，特别是用于医药的组合物，该组合物包括含有氰基丙烯酸酯单体的成分 a) 和含水成分 b)，其中该组合物还包括一种酸和一种盐，该盐与酸反应释放出一种气体。 本发明还涉及一种可从该组合物中获得的反应产物，其形式尤其为多孔且形状稳定的发泡结构。 本发明还涉及一种试剂盒，该试剂盒包括在空间上相互分离的酸组分 a) 和盐组分 b)，还涉及一种涂抹器，该涂抹器具有一个装有酸组分 a) 的第一腔室和一个装有盐组分 b) 的第二腔室。
• CURABLE TWO-PART ADHESIVE COMPOSITION
  申请人：Bostik SA

  公开号：EP3943521A1

  公开（公告）日：2022-01-26

  The present invention refers to a curable two-part adhesive composition comprising a first part comprising one or more cyanoacrylate monomer(s), one or more (metha)acrylate monomer(s), a per-compound and, optionally, additives to control viscosity and rheology; and a second part comprising: a non-reactive diluent and a transition metal catalyst, and optionally an electron rich initiator for cyanoacrylates. It also relates to a syringe or a cartridge comprising said two-part curable composition, to the use of such composition for bonding substrates, to the use of such composition filling depressions, cracks or holes in a substrate or between substrates to a method for bonding substrates using said composition, and to a repair method for filling depressions, cracks or holes in a substrate or between substrates using said composition.

  本发明涉及一种可固化的双组分粘合剂组合物，其第一部分包括一种或多种氰基丙烯酸酯单体、一种或多种（甲基）丙烯酸酯单体、每种化合物以及可选的控制粘度和流变性的添加剂；第二部分包括：非反应性稀释剂和过渡金属催化剂，以及可选的氰基丙烯酸酯富电子引发剂。它还涉及包含所述双组分可固化组合物的注射器或注射筒，涉及使用这种组合物粘合基材，涉及使用这种组合物填补基材或基材之间的凹陷、裂缝或孔洞，涉及使用所述组合物粘合基材的方法，以及涉及使用所述组合物填补基材或基材之间的凹陷、裂缝或孔洞的修复方法。
• COMPOSITION, REACTION PRODUCT, KIT AND APPLICATOR, ESPECIALLY FOR USE IN MEDICINE
  申请人：AESCULAP AG

  公开号：EP2708245B1

  公开（公告）日：2019-03-20
• TWO-PART CURABLE COMPOSITION
  申请人：Bostik SA

  公开号：EP3941987A1

  公开（公告）日：2022-01-26
• [EN] TWO-PART CURABLE COMPOSITION<br/>[FR] COMPOSITION DURCISSABLE EN DEUX PARTIES
  申请人：BOSTIK SA

  公开号：WO2020187963A1

  公开（公告）日：2020-09-24

  The present invention concerns a two-part curable composition comprising: • a first part (component A) comprising at least 51 % by weight based on the total weight of the first part, of one or more cyanoacrylate monomer(s), provided that at least one of the cyanoacrylate monomer(s) is a cyanoacrylate monomer comprising a group -X-O- Rb wherein X is a linear or branched alkylene radical optionally interrupted with one or several oxygen atom(s), and Rb is an alkyl group; • a second part (component B) comprising: at least one Michael acceptor M selected from the group consisting of (meth)acrylic monomers, (meth)acrylic functionalized oligomers, (meth)acrylic functionalized resins, and mixtures thereof, provided that at least one of the Michael acceptor(s) M comprises at least one group of formula -0(CHRa-CH2O)n- where n ranges from 1 to 10 (Michael acceptor M1), and Ra represents CH3 or H; and a nucleophilic initiator; the second part being characterized in that: - the total content of Michael acceptor(s) M1 is of at least 20% by weight based on the total weight of the second part; and - it does not comprise cyanoacrylate monomer.